rs772180415
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong
The NM_000520.6(HEXA):c.964G>T(p.Asp322Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000041 in 1,461,746 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. D322E) has been classified as Uncertain significance.
Frequency
Consequence
NM_000520.6 missense
Scores
Clinical Significance
Conservation
Publications
- Tay-Sachs diseaseInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| HEXA | NM_000520.6 | c.964G>T | p.Asp322Tyr | missense_variant | Exon 8 of 14 | ENST00000268097.10 | NP_000511.2 | |
| HEXA | NM_001318825.2 | c.997G>T | p.Asp333Tyr | missense_variant | Exon 8 of 14 | NP_001305754.1 | ||
| HEXA | NR_134869.3 | n.1006G>T | non_coding_transcript_exon_variant | Exon 8 of 11 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000796 AC: 2AN: 251390 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000410 AC: 6AN: 1461746Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727188 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Tay-Sachs disease Pathogenic:6
The missense variant p.D322Y in HEXA (NM_000520.6) has been reported previously in multiple affected individuals of Indian origin(Sheth J et al, Mistri M et al). The variant has been submitted to ClinVar as Likely Pathogenic/Pathogenic. The p.D322Y variant is observed in 2/30,616 (0.0065%) alleles from individuals of South Asian background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.D322Y missense variant is predicted to be damaging by both SIFT and PolyPhen2. The aspartic acid residue at codon 322 of HEXA is conserved in all mammalian species. The nucleotide c.964 in HEXA is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Pathogenic. -
This variant found to be pathogenic by online software including Mutation Taster, Polyphen2 and SIFT. -
This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 322 of the HEXA protein (p.Asp322Tyr). This variant is present in population databases (rs772180415, gnomAD 0.006%). This missense change has been observed in individual(s) with Tay-Sachs disease (PMID: 22390110, 22723944, 23852624). ClinVar contains an entry for this variant (Variation ID: 221281). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt HEXA protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic. -
Variant summary: HEXA c.964G>T (p.Asp322Tyr) results in a non-conservative amino acid change located in the Glycoside hydrolase family 20, catalytic domain (IPR015883) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 8e-06 in 251390 control chromosomes (gnomAD). c.964G>T has been reported in the literature in multiple compound heterozygous and homozygous individuals affected with Tay-Sachs Disease, gangliosidosis and suspected neurological disorders (Chan_2011, Sheth_2013, Ganapathy_2019, Mistri_2019, Gowda_2020). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 22390110, 31069529, 35186388, 31388111, 22723944, 23852624). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic (n=1) and likely pathogenic (n=2). Based on the evidence outlined above, the variant was classified as pathogenic. -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at